Apps

Finance

HCA Healthcare Reports Strong Q2 Earnings, Revenue Rise

HCA Healthcare reported Q2 revenue of $20.23 billion, up 8.7% year over year, with net income of $1.699 billion and diluted EPS of $7.62, while adjusted EBITDA rose to $4.027 billion and the company kept its 2026 EPS guidance at $28.70–$30.50 as it cited higher uninsured volumes and lower surgical activity; the stock rose about 1.3%. Analysts pared their targets after softer Q2 results and guidance, with Wells Fargo trimming to $369 and Barclays to $402, while noting a need for stronger organic growth later in 2026.

Barclays PLC

Comments

Rosen Law investigates securities claims against four entities

HCA Healthcare Reports Strong Q2 Earnings, Revenue Rise

Barclays PLC

Overview

Comments

Rosen Law investigates securities claims against four entities

HCA Healthcare Reports Strong Q2 Earnings, Revenue Rise

Overview

Analysts Trim Celldex Price Targets, Shares Fall

Revolut Hits $115B Valuation in Secondary Sale

Momentum

Barclays PLC across IJR

Barclays PLC across IJR